Medication review is the framework’s main analytical step. The pharmacist examines the patient’s medicines systematically, looking for therapeutic problems and safety risks rather than considering each prescription in isolation. This assessment creates the basis for evidence-informed recommendations and subsequent monitoring, helping the care team connect medicine-related findings with decisions about ongoing therapy.
Communication turns a pharmacist’s assessment into coordinated action. Recommendations are shared with prescribers, while relevant medicine information and follow-up guidance are communicated to patients. This exchange helps align prescribing decisions with the patient’s therapy and supports a shared understanding of problems, proposed changes, and monitoring needs across the people involved in care.
Continuity helps preserve a consistent understanding of a patient’s medicines when care moves between settings. By linking assessment, prescribing support, dispensing, and follow-up, the framework provides a reproducible way to carry medicine-related information forward. This can reduce gaps in management, support adherence, and keep safety concerns visible during ongoing treatment.
Dispensing supplies medicines, whereas this framework connects dispensing with clinical assessment, prescribing support, communication, and follow-up. The pharmacist therefore contributes to decisions about how therapy is used, not only to the supply process. That broader connection allows therapeutic problems and safety risks identified during review to inform subsequent care and monitoring.
Application begins with a systematic review of the patient’s medicines. The pharmacist then identifies therapeutic problems or safety risks, develops evidence-informed recommendations, and communicates them with prescribers and the patient. Dispensing and follow-up remain connected to this assessment, while monitoring provides an opportunity to evaluate medicine use and continue coordinated management.
The approach is useful when medicine management requires coordination among pharmacists, prescribers, and patients, particularly across different care settings. It provides a structured basis for reviewing therapy, addressing safety concerns, supporting adherence, and maintaining follow-up. Its relevance extends beyond a single dispensing encounter because it links medicine-related decisions with continuing patient care.
The framework can support safer and more effective therapy by making medicine-related problems and risks part of routine decision-making. Its coordinated review and follow-up may improve adherence, strengthen continuity, and promote patient-centered care. These outcomes depend on connecting clinical pharmacy expertise with prescribing decisions, patient communication, and ongoing monitoring rather than treating each activity separately.